Evidence map›Paper›PMID 27461405›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2016

Levodopa modulates small-world architecture of functional brain networks in Parkinson's disease.

Brian D Berman, Jason Smucny, Korey P Wylie, Erika Shelton, Eugene Kronberg, Maureen Leehey, Jason R Tregellas

Abstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Non-motor correlates of anxiety inFrontiers in neuroscience · 2026
    Article
  9. Article
  10. Effects of levodopa on motor and cerebellar network connectivity in Parkinson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Brian D BermanDepartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Jason SmucnyDepartment of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Korey P WylieDepartment of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Erika SheltonDepartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Eugene KronbergDepartment of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Maureen LeeheyDepartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Jason R TregellasDepartment of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Funding

Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Development of Psychopathology, Psychobiology, & BehaviorT32MH015442 · NIMH · UNIVERSITY OF COLORADO DENVER · PI JASON R TREGELLAS · 1985 to 2026
$10.2M
Trajectories and Markers of Neurodegeneration in Fragile X Premutation CarriersR01MH078041 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HESSL, DAVID R, RIVERA, SUSAN M · 2007 to 2017
$5.4M
Colorado Clinical and Translational Sciences InstituteKL2TR001080 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$2.6M
Neuronal Effects of Exercise on SchizophreniaR01MH102224 · NIMH · UNIVERSITY OF COLORADO DENVER · PI TREGELLAS, JASON R · 2014 to 2018
$1.9M
Nicotinic Agonist Effects on BMI and Neuronal Response in Overweight/Obese AdultsR01DK103691 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI TREGELLAS, JASON R · 2015 to 2019
$1.9M
Functional Imaging of the Nicotinic Basis for Attention Deficits in SchizophreniaF31MH102879 · NIMH · UNIVERSITY OF COLORADO DENVER · PI SMUCNY, JASON · 2014 to 2016
$76k
fMRI of Cholinergic Mechanisms in SchizophreniaI01CX000459 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI TREGELLAS, JASON R · 2011 to 2015
–
CSRD VA I01 CX000459NCATS NIH HHS KL2 TR001080NCATS NIH HHS UL1 TR001082NIDDK NIH HHS R01 DK103691NIMH NIH HHS F31 MH102879NIMH NIH HHS R01 MH078041NIMH NIH HHS R01 MH102224NIMH NIH HHS T32 MH015442
6 · The paper itself

Abstract

backgroundPD is associated with disrupted connectivity to a large number of distributed brain regions. How the disease alters the functional topological organization of the brain, however, remains poorly understood. Furthermore, how levodopa modulates network topology in PD is largely unknown. The objective of this study was to use resting-state functional MRI and graph theory to determine how small-world architecture is altered in PD and affected by levodopa administration.

methodsTwenty-one PD patients and 20 controls underwent functional MRI scanning. PD patients were scanned off medication and 1 hour after 200 mg levodopa. Imaging data were analyzed using 226 nodes comprising 10 intrinsic brain networks. Correlation matrices were generated for each subject and converted into cost-thresholded, binarized adjacency matrices. Cost-integrated whole-brain global and local efficiencies were compared across groups and tested for relationships with disease duration and severity.

resultsData from 2 patients and 4 controls were excluded because of excess motion. Patients off medication showed no significant changes in global efficiency and overall local efficiency, but in a subnetwork analysis did show increased local efficiency in executive (P = 0.006) and salience (P = 0.018) networks. Levodopa significantly decreased local efficiency (P = 0.039) in patients except within the subcortical network, in which it significantly increased local efficiency (P = 0.007).

conclusionsLevodopa modulates global and local efficiency measures of small-world topology in PD, suggesting that degeneration of nigrostriatal neurons in PD may be associated with a large-scale network reorganization and that levodopa tends to normalize the disrupted network topology in PD. © 2016 International Parkinson and Movement Disorder Society.

Indexed as

BrainConnectomeNerve NetParkinson DiseaseAgedAntiparkinson AgentsFemaleHumansLevodopaMagnetic Resonance ImagingMaleMiddle AgedAntiparkinson AgentsLevodopagraph theorylevodopaParkinson diseaseresting-state fMRI

Identifiers

PMID27461405
PMCPMC5115928

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.